Rare-Earth modified biodegradable Zn alloys with high strength and enhanced osteogenesis Authors: Jiahui Shi, Mingyu Qu, Chaoyang Sun, Shuang Li, Jialian Xu, Ting Zhang, Xinhua Qu, Hongtao Yang, Yufeng Zheng Published: 2026 ABSTRACT AbstractAchieving high strength and robust osteogenesis simultaneously remains a challenge for biodegradable orthopedic materials. Here we show that incorporating trace rare-earth (RE) elements into a Zn-Li-Mn system bridges this gap. By forming REZn11-13 intermetallic phases, we engineer a bimodal grain structure that elevates tensile strength to 772 MPa and bending strength to 1207 MPa, approaching the level of medical-grade titanium alloy (Ti-6Al-4V) while retaining biodegradability. Crucially, these phases act as “potential-buffering” electrodes, ensuring uniform degradation and controlled zinc ion release. This optimized ion concentration activates the Rap1 signaling pathway, resulting in twofold greater bone regeneration compared to titanium alloy implants. By integrating ultrahigh mechanical strength with potent bioactivity, this Zn-Li-Mn-Y alloy provides a superior platform for next-generation load-bearing implants, offering a degradable alternative to permanent metallic fixations.Subject terms: Biomedical materials, Implants, Tissue engineering Introduction The development of bone repair materials that simultaneously exhibit high mechanical strength, biodegradability, and osteogenic activity remains an unmet challenge in orthopedics. Clinically, fracture fixation of load-bearing bones such as the femur and tibia still relies heavily on biologically inert titanium alloys, due to their superior strength. However, long-term implantation often leads to foreign-body reactions1–3 and stress shielding–induced bone resorption4,5, necessitating secondary removal surgeries and making these materials unsuitable for complex conditions such as osteoporotic fracture repair. Zinc (Zn), an essential trace element in bone metabolism, has demonstrated the ability to promote bone regeneration at appropriate concentrations6. Owing to its higher mechanical strength compared to biodegradable magnesium alloys, biodegradable Zn alloys have emerged as a promising new generation of orthopedic materials7–12. Our previous work developed a Zn-Li binary system (0.1 ≤ Li ≤ 0.8 wt%)9, which achieves a tensile strength comparable to that of medical-grade pure titanium and 316 L stainless steel (ultimate tensile strength, UTS 350–600 MPa), while its degradation products effectively activate the PI3K/AKT signaling pathway to accelerate fracture healing13. During solidification, a unique eutectic followed by eutectoid reactions give rise to an ultrafine lamellar microstructure (Zn + LiZn₄, ~300 nm interspacing), which effectively impedes dislocation motion and crack propagation, leading to exceptional strengthening. However, excessive Li content promotes overdevelopment of this lamellar phase, resulting in material embrittlement8,14. To overcome this limitation, trace addition of Mn produced a Zn-0.8Li-0.1Mn ternary alloy, achieving a balanced combination of high strength (UTS 550 MPa) and good ductility (E 68%)9,15. Nevertheless, its strength still falls short of that of Ti-6Al-4V alloys (UTS 850 MPa)16. Microstructural analysis of Zn-0.8Li-0.1Mn alloy revealed a considerable fraction of equiaxed Zn grains, suggesting further optimization potential9. Our systematic screening of 16 rare-earth (RE) elements in binary Zn-RE alloys revealed that Y, Gd, Eu, Nd, and Sm can significantly enhance the strength and corrosion uniformity of Zn by refining equiaxed grains and precipitating RE-containing second phases17. Importantly, studies on Mg-Li-RE systems18,19 indicate that these RE elements do not form intermetallic compounds with Li, suggesting their potential compatibility with the Zn-Li-Mn matrix. Thus, we hypothesized that introducing trace RE elements into the Zn-Li-Mn system could further refine the equiaxed Zn grains, enhance mechanical strength, improve degradation homogeneity, and potentiate osteogenic bioactivity. Based on this rationale, we designed and fabricated a new family of Zn-0.8Li-0.1Mn-RE quaternary alloys (ZLM-RE, RE = Y, Gd, Eu, Nd, Sm). Considering that RE elements are non-essential to the human body, we limited their content to 0.3 or 0.5 wt%, forming only a minor fraction of intermetallic phases, as supported by previous in vivo biocompatibility evaluations of Zn-RE systems. We systematically investigated their mechanical properties, microstructural evolution, and strengthening mechanisms, followed by comprehensive characterization of their electrochemical corrosion behavior, cytocompatibility, and osteogenic functionality. Using a critical-sized bone defect model, we further evaluated the in vivo degradation kinetics and bone regeneration performance of the ZLM-RE implants and elucidated their underlying osteogenic mechanisms. Remarkably, the optimized Zn-0.8Li-0.1Mn-0.5Y alloy achieved a tensile strength of 772 MPa and a bending strength of 1207 MPa)—approaching that of Ti-6Al-4V alloys —while exhibiting twice the osteogenic efficacy of Ti-6Al-4V. This work propelling biodegradable metallic implants toward clinical application in load-bearing bone repair, and marks a significant step forward in the development of next-generation ultrahigh strength, degradable and bioactive orthopedic materials. Results Mechanical property The microstructures and mechanical properties of Zn-0.8Li-0.1Mn-RE (ZLM-RE) alloys are summarized in Fig. 1. As shown in Fig. 1A, B, RE-containing intermetallic phases are clearly observed in all ZLM-RE alloys (highlighted by red arrows). The diffraction peaks of REZn(11–13) compounds are identified in Fig. 1C and Supplementary Fig. S1, along with the LiZn4 and Zn phases. The presence of these hard and brittle REZn(11–13) phases provides a reasonable explanation for the observed strength–ductility trade-off in the ZLM-RE alloys. Mechanical properties and microstructure of Zn-0.8Li-0.1Mn-RE (ZLM-RE) alloys. A Phase diagram of Zn-RE (RE = Y, Gd, Sm, Eu, Nd) alloys. B X-ray diffraction (XRD) patterns of the ZLM and ZLM-RE alloys. C Backscattered image of the second phases in ZLM and ZLM-RE alloys. D Ultimate tensile strength (UTS), yield tensile strength (YTS), elongation and vicker hardness (HV) of ZLM-RE alloys, n = 3. Measurements were taken from distinct samples. The dashed line represents the performance level of the Zn-0.8Li-0.1Mn (ZLM) alloy. Data are presented as mean ± standard deviation. E UTS versus elongation for common medical metals and their potential orthopedic applications. The data points are presented in Supplementary Table 1. P-values are calculated using one-way ANOVA with Tukey’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.005. Source data is available for (B, D, E) in the associated source data file and Supplementary Table 1. Overall, the addition of RE elements (Y, Gd, Sm, Eu, Nd) significantly increases the tensile strength and microhardness of the Zn-Li-Mn alloy, though at the expense of plasticity (Fig. 1D). Among them, Y exhibits the most pronounced strengthening effect. In particular, the ZLM-0.5Y alloy achieves an ultimate tensile strength (UTS) of 772 MPa, representing a 40% improvement compared with the original ZLM alloy and approaching the strength level of Ti-6Al-4V. Figure 1E illustrates the progressive optimization of Zn alloy design in our work. Initially, Li was identified as an effective strengthening element for Zn, enabling its tensile strength to surpass that of pure Ti. The subsequent addition of Mn was found to enhance the plasticity and formability of Zn-Li alloys, making Zn-Li-Mn (ZLM) alloys suitable for load-bearing bone implants (UTS 400–550 MPa). Building on this foundation, the incorporation of selected RE elements further improves strength, leading to the development of quaternary Zn alloys. Notably, the Zn-0.8Li-0.1Mn-0.5Y alloy demonstrates the highest strength, reaching a level comparable to the widely used high-load-bearing Ti-6Al-4V alloy. Microstructure To further understand how the mechanical properties of the ZLM-RE alloy are influenced by individual alloying elements, we systematically characterized the microstructures of pure Zn, Zn-0.8Li, Zn-0.8Li-0.1Mn, and Zn-0.8Li-0.1Mn-0.5Y alloys (Fig. 2). In the following descriptions, the specific concentrations of the alloying elements will be abbreviated for simplicity and clarity. EBSD and pole figure analyses reveal that hot-extruded pure Zn consists of deformed grains and recrystallized equiaxed grains, exhibiting a (0001) basal texture parallel to the extrusion direction. Kernel average misorientation (KAM) maps indicate that stresses in pure Zn are primarily concentrated within the deformed grains. EBSD and TEM results of Zn, Zn-Li, Zn-Li-Mn, and Zn-Li-Mn-Y alloys. A EBSD grain orientation maps, grain size distribution maps (inserted), inverse pole figures (IPF) of Zn phase in extruded direction (ED), and KAM residual stress maps. The magnification in Zn-Li-Mn-Y alloy indicates YZn12 second phase and local stress between YZn12 and Zn equiaxed matrix. B TEM bright-field images and corresponding high-resolution images, EDS mapping and diffraction patterns at phase interfaces. Each image was acquired independently three times, with similar results. Source data is available for (A) in the associated source data file. After alloying with Li, the microstructure is composed of equiaxed Zn grains and a lamellar eutectic structure (Zn + LiZn₄) formed through eutectoid followed by eutectic transformations. The equiaxed grain size is markedly refined, decreasing from 100–300 μm to only a few micrometers. At the same time, the texture undergoes a pronounced change: in addition to the original (0001) texture originating from equiaxed grains, a secondary texture—likely associated with the eutectoid lamellae—emerges, and the overall texture intensity nearly doubles. In the Zn-Li alloy, stress is mainly localized within the eutectic lamellae, while recrystallization effectively eliminates stresses within the equiaxed grains. With the addition of Mn, the equiaxed grains are further refined and the texture intensity becomes weaker. In the quaternary Zn-Li-Mn-Y alloy, the grain size exhibits a bimodal distribution: besides fine grains smaller than 10 μm (equiaxed Zn phase), about one-quarter of the grains are coarser, with sizes of ~50 μm (YZn12 phase, Supplementary Fig. 2), and the fraction of recrystallized grains decreases. Moreover, the Zn-Li-Mn-Y alloy shows the strongest dual-texture characteristics, with stress distributed in both the equiaxed grains and the eutectic lamellae. Pronounced stress concentration (white circle in Fig. 2A) is observed particularly at the interfaces between the YZn₁₂ phase (marked by white arrows) and the Zn matrix. Transmission electron microscopy (TEM) was further employed to investigate the morphology, interfaces, and lattice structures of the eutectic lamellae (Zn + LiZn₄) and the YZn₁₂ phase in the Zn-0.8Li-0.1Mn-0.5Y alloy. In the eutectoid regions, Zn and LiZn₄ phases are arranged alternately in a lamellar pattern with an interlamellar spacing of ~300 nm, and the c-axes of the two phases are rotated by 90°. The YZn₁₂ phase is mainly distributed within the equiaxed grain regions. At the Zn/YZn₁₂ interfaces, the crystal lattices on either side exhibit no continuity or defined orientation relationship, with disordered atomic arrangements indicative of incoherent interfaces. In situ mechanical performance of Zn-Li-Mn-Y alloy To further elucidate the strengthening and deformation mechanisms of the Zn-Li-Mn-Y alloy, in situ SEM tensile testing combined with EBSD was employed to dynamically analyze the role of the YZn₁₂ phase during deformation (Fig. 3A). During the elastic deformation stage, a clear crystallographic misorientation exists between the YZn₁₂ phase and the Zn matrix, and the stress concentration within the YZn₁₂ phase remains relatively weak. Upon reaching the yield point, the texture intensity of both the Zn matrix and the YZn₁₂ phase increases, accompanied by a pronounced increase in stress concentration within the YZn₁₂ phase and the initiation of microcracks. As deformation proceeds into the plastic regime, most YZn₁₂ particles undergo cracking, and the texture intensity no longer increases. The cracks propagate from the fractured YZn₁₂ phase into the surrounding Zn matrix, ultimately leading to macroscopic fracture of the alloy. Owing to the high density of defects generated at this stage, the indexing rate of the YZn₁₂ phase and its surrounding regions decreases. In situ mechanical performance of Zn-Li-Mn-Y alloy. A Stress-strain curve and SEM, EBSD grain orientation maps, KAM residual stress maps, and IPF (ED) of selected points (elastic deformation, yielding point, and plastic deformation) during in situ tension test. B Compression and C bending stress-strain curve and corresponding strength, n = 3. Measurements were taken from distinct samples (CYS compression yield strength, UCS ultimate compression strength, BYS bending yield strength, UBS ultimate bending strength). Data are presented as mean ± standard deviation. P-values are calculated using one-way ANOVA with Tukey’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.005. Source data is available for (B, C) in the associated source data file. In addition, the deformation behavior of the Zn-Li-Mn-Y alloy under different loading modes was evaluated by compression and bending tests. The Zn-Li-Mn-Y alloy exhibits good compressive plasticity, with a compressive strength (681 MPa) superior to that of the Zn-Li-Mn alloy (583 MPa) (Fig. 3B). In contrast, during bending tests, the Zn-Li-Mn-Y exhibited an ultimate bending strength of 1207 MPa, while the bending ductility of the Zn-Li-Mn-Y alloy is reduced compared to Zn-Li-Mn alloy (Fig. 3C). Furthermore, a comparison of the creep behavior between the two alloys indicates that the addition of Y leads to a deterioration in creep resistance (Supplementary Fig. 3). In vitro degradation behavior Figure 4 illustrates the electrochemical characteristics, in-vitro immersion corrosion behavior, and corrosion products of ZLM-RE alloys. Potentiodynamic polarization curves revealed that the addition of Y, Gd and Eu reduced the corrosion current density of the ZLM alloy (Supplementary Table 2), while the incorporation of Sm and Nd led to a pronounced passivation process during anodic polarization (Fig. 4A). Overall, RE alloying increased the surface impedance, with the most significant change observed in ZLM-Sm. After one month of immersion in simulated body fluid (SBF), optical microscopy showed that alloys containing 0.5Y or 0.3Eu, Gd, and Sm predominantly exhibited a macroscopically uniform corrosion pattern (Fig. 4B). Weight-loss measurements indicated no significant differences in corrosion rates among the groups, suggesting that the minor addition of rare-earth elements mainly alters the corrosion mode without substantially affecting the overall corrosion rate (Fig. 4C). Monitoring of the solution pH demonstrated only a slight increase during alloy degradation (from 7.4 to 7.5 over 30 days). The corrosion products were primarily composed of Zn, C, O, P, and Ca. XRD, FTIR, and XPS analyses confirmed that the main products were ZnO, Zn3(PO4)2, and Ca-P complexes, while no obvious solid-state products derived from the alloying elements were detected (Fig. 3D). Corrosion behavior of ZLM-RE alloys in simulated body fluid (SBF). A Tafel curves and electrochemical impedance spectra (EIS) of alloys in SBF. The calculated corrosion densities are listed in Supplementary Table 2. B Corrosion morphology of alloys after 28 days’ immersion in SBF. C Corrosion rates calculated from weight loss and recorded pH after 28 days, n = 3. Data are presented as mean ± standard deviation. Measurements were taken from distinct samples. D Quantitative EDS, X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectra, and X-ray photoelectron spectroscopy (XPS) analysis of corrosion products. X-ray diffraction (XRD) analysis of corrosion products. Source data is available for (A, C, D) in the associated source data file. Cytocompatibility The cytocompatibility of ZLM-RE alloys was evaluated using the MC3T3-E1 cell line. When cultured with 100% extraction medium, evident cytotoxicity was observed; however, the ZLM-0.3Gd alloy exhibited better cytocompatibility compared with ZLM and the other alloys (Supplementary Fig. 4A). Upon a twofold dilution of the extracts, all ZLM-RE alloy groups showed no cytotoxicity, and by day 4 of culture, cell proliferation rates were significantly higher than those of the blank control. In alloy extracts, Zn and Li ion concentrations significant decreased in ZLM-RE alloys compared to ZLM alloy. Live/Dead staining further revealed that, relative to the Ti-6Al-4V alloy, the diluted ZLM-RE alloy extracts supported a noticeably higher number of cells (Supplementary Fig. 4B). Immunofluorescence staining images confirmed that, under diluted ZLM-RE extract conditions, MC3T3-E1 cells displayed round, well-defined nuclei and a well-spread cytoskeletal structure (Supplementary Fig. 4C). In vitro osteogenesis To further validate the osteogenic-promoting effects of ZLM-0.5Y, ZLM-0.3Gd, and ZLM-0.3Eu, Supplementary Fig. 5A, B shows the ALP staining results of MC3T3 cells cultured with one-fold diluted extract solutions for 7 and 14 days. As an early marker of osteogenic differentiation, ALP staining revealed that all Zn alloy treatment groups exhibited markedly stronger staining intensity compared to the control group. In particular, the ZLM-0.3Gd and ZLM-0.5Y groups demonstrated the most pronounced enhancement of osteogenic differentiation. Furthermore, BMP2, a key regulatory molecule in osteogenesis, was significantly upregulated in all three alloy-treated groups after 7 days of incubation. ARS staining, which evaluates mineralized nodule formation, further confirmed these findings. The alloy-treated groups displayed a substantially greater number and more homogeneous distribution of mineralized nodules than the control group, indicating a superior promotion of the bone mineralization process. Consistently, the qPCR results (Supplementary Fig. 5C) showed that after 7 and 14 days of treatment, the expression levels of key osteogenic genes (Runx2, ALP, Osx, OPN, and Col1) were significantly higher in the alloy groups compared to the control. Notably, Runx2 and ALP exhibited particularly strong upregulation, underscoring the alloys’ potent stimulatory effects on osteogenic differentiation. In vivo osteogenesis Subsequently, as-extruded ZLM-RE alloy implants were inserted into a rat femoral condyle critical-sized bone defect model to evaluate their effects on bone regeneration. Micro-CT imaging and 3D reconstruction (Fig. 5A) performed one months post-implantation revealed that, compared with the Ti-6Al-4V control group, all ZLM-RE alloy implants exhibited greater new bone formation surrounding the implant sites. Notably, the ZLM-0.3Gd, ZLM-0.5Y, and ZLM-0.3Eu groups demonstrated significant increases in bone volume, bone area ratio, and bone radius parameters. Osteogenesis promotion effects of ZLM-RE alloys implants in a rat femoral condyles critical defect model at 1month. A CT reconstruction images and quantitative analysis (n = 5, bone volume/tissue volume, BV/TV) showing the bone tissue regeneration around ZLM-RE alloys. B Representative Van Gieson staining of implants and new bone with calculated bone area ratios, n = 3. P-values are calculated using one-way ANOVA with Tukey’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.005. Measurements were taken from distinct samples. For box-whisker plots, box edges correspond to 25th and 75th percentiles, lines inside the box correspond to 50th percentiles, and whiskers include minimum and maximum of all data points. For bar plots, data are presented as mean ± standard deviation. Source data is available for (A, B) in the associated source data file. Further histological staining confirmed these findings (Fig. 5B), showing more abundant and thicker trabecular bone formation around the ZLM-RE alloy implants, whereas only sparse trabeculae were observed near the Ti-6Al-4V implants. Among all tested alloys, the ZLM-0.3Gd and ZLM-0.5Y groups exhibited the most pronounced new bone formation and trabecular development. In vivo degradation To further investigate the effects of implant degradation and metal ion release on bone regeneration, XRF analysis was conducted (Fig. 6A). XRF is capable of detecting trace elements at concentrations as low as the ppm level. Compared with the Ti-6Al-4V group, the ZLM-RE alloy implants exhibited weak zinc signals (indicated by white arrows) on their surfaces, corresponding to Zn released during degradation and uniformly distributed around the implant sites. Scanning for all six RE elements revealed no detectable distribution or accumulation of these elements in the surrounding tissues. In vivo degradation behavior of ZLM-RE alloy implants at 3 months. A Backscattered electron images (BSE) and corresponding X-ray Fluorescence Spectrometer (XRF) elemental mapping of cross section of implants. White arrows indicate Zn degradation, yellow dashed circles indicate the contour of implants. The intensity and distribution of elemental signals are marked by color ribbon. B Second electron images of implant-bone interface and corresponding elemental mapping. NB new bone, FB fibrous tissue. Each image was acquired independently three times, with similar results (A, B). High-magnification analysis of the implant–bone interface further demonstrated a thin layer (~50 μm) of interfacial tissue between the newly formed bone and the ZLM-RE alloy implants, along with minor surface degradation products (Fig. 6B). In contrast, the Ti-6Al-4V implants showed no detectable element release or degradation products, and almost no fibrous tissue was observed between the implant and the new bone. Histology and transcriptomic analysis To further investigate the in vivo osteogenic effects of the ZLM-Gd/Y/Eu alloys, Fig. 7A presents the immunohistochemical staining results for osteogenesis (COL-1, OPN) and immune related markers (IL-10, TNF-α) at the implantation sites. More intense inflammation can be observed in ZLM-RE alloy groups at 1 month compared to Ti-6Al-4V alloy group, which subsides at 3 months. Higher IL-10 expression compared to TNF-α indicates that pro-healing related macrophages dominate at 1 and 3 months. ZLM-RE alloy groups showed higher expression of IL-10 than the Ti-6Al-4V alloy group. Meanwhile, the expression levels of COL-1 and OPN were markedly higher in ZLM-RE alloy groups compared to the Ti-6Al-4V control, confirming that these alloys effectively promote new bone formation (H&E and Masson). Histological staining and transcriptomic analysis. A Immunohistochemistry of H&E, Masson, COL-1, OPN, IL-10, and TNF-α of ZLM-0.3Gd, ZLM-0.5Y, ZLM-0.3Eu and Ti-6Al-4V alloy groups at the implantation site at 1 and 3 months. Each image was acquired independently at least three times, with similar results. B GO term enrichment and significantly upregulated KEGG pathways in ZLM-0.5Y compared to the control group. Source data is available for (B) in the NIH National Center for Biotechnology Information Bioproject database under accession number PRJNA1417620. To elucidate the molecular mechanisms underlying the osteogenic stimulation induced by the ZLM-RE alloys, ZLM-0.5Y was selected for further analysis owing to its optimal balance between osteogenic activity and mechanical strength. RNA sequencing of MC3T3-E1 cells cultured with ZLM-0.5Y extract revealed a significant upregulation of the Rap1 signaling pathway (Fig. 7B). GO enrichment analysis demonstrated that the differentially expressed genes were significantly enriched in biological processes associated with osteogenesis and cell differentiation. Notably, pathways such as “skeletal system development,” “regulation of osteoblast differentiation,” and “regulation of ossification” were prominently upregulated. Moreover, genes involved in cell migration and morphological regulation, including “regulation of cell migration” and “regulation of cell motility,” were also enriched. Collectively, these findings indicate that ZLM-0.5Y promotes osteogenic differentiation by upregulating multiple genes involved in bone formation, thereby facilitating MC3T3-E1 cell maturation and enhancing bone matrix deposition. Biosafety evaluation Supplementary Fig. 6 shows no evidence of systemic toxicity after 3 months of implantation of the ZLM-RE alloy. Histopathological evaluation of the heart, liver, spleen, lungs, and kidneys revealed preserved architecture without inflammatory infiltrates or other pathological lesions. Consistently, serum biochemistry—including ALT, AST, ALP, total protein, creatinine, urea, and lipid parameters—remained within reference ranges and did not differ significantly from controls. These findings indicate favorable systemic tolerability of the biodegradable ZLM-RE alloy at 3 months. This benign systemic profile aligns with the in vivo degradation behavior shown in Fig. 7, in which the alloy corrodes at a moderate rate and releases ions in a controlled manner, thereby preventing abrupt increases in circulating metal ions and avoiding acute toxicity. Similarly, the attenuated inflammatory response in Fig. 8 corroborates these safety outcomes: higher IL-10 relative to TNF-α suggests predominance of pro-healing macrophage phenotypes at 1 and 3 months, and stable lymphocyte ratios argue against a chronic immune response. Collectively, Figs. 6 and 7 demonstrate that the ZLM-RE implant undergoes controlled degradation while maintaining normal physiological conditions over 3 months, supporting its biosafety. Schematic desccribing the properties optimazing mechanism of Zn-Li-Mn-Y alloy. A Schematic showing the microstructure and strengthening effects in Zn-0.8Li-0.1Mn (ZLM) and Zn-0.8Li-0.1Mn-0.5Y (ZLM-0.5Y) alloys. B Evans diagram indicating how the galvanic reactions in three electrodes system (Zn, YZn13, and LiZn4). Ia: anodic corrosion density, Ic: cathodic corrosion density, Ig: galvanic corrosion density. C Schematic indicating the osteogenesis signal pathways activated by ion release from the degradation of implants. Some elements were created with BioRender under a publication license for open-access resources. Discussion Bone repair materials that simultaneously possess ultra-high strength, biodegradability, and osteogenic activity remain absent in current orthopedic clinical practice. In our previous work, we discovered that Zn-Li alloys undergo a unique solidification process—eutectic followed by eutectoid reactions—during cooling, resulting in an ultrafine lamellar microstructure with an interlamellar spacing of approximately 300 nm13. This microstructure effectively impedes both dislocation motion and crack propagation, synergistically enhancing the alloy’s strength and toughness. Consequently, the highest UTS of this alloy system exceeds 700 MPa in Zn-1.2Li alloy, making it the only biodegradable bone repair material whose strength surpasses that of medical-grade pure titanium and Ti-Nb-Zr-Ta alloy8. Moreover, in both normal and osteoporotic fracture or bone defect models, Zn-Li alloys exhibit remarkable osteogenic performance. Their degradation leads to the co-release of Zn²⁺ and Li⁺ ions, which significantly activate the PI3K/AKT signaling pathway and promote bone regeneration13. These features render Zn-Li alloys suitable for load-bearing orthopedic implants such as bone plates, screws, and intervertebral cages. However, the improvement of Zn-Li alloy strength comes at the expense of plasticity. Further alloying with Mn produces ternary Zn-Li-Mn (ZLM) alloys, which substantially enhance plasticity to above 50%. Nevertheless, their strength still lags behind conventional ultra-high-strength biomedical alloys such as Ti-6Al-4V alloy (UTS 850 MPa). Rare earth (RE) elements are widely employed in high-performance alloys for aerospace and marine applications due to their remarkable effects on mechanical and corrosion properties. Human bones, constantly subjected to dynamic loading in a complex physiological environment, demand materials with finely tuned degradation behaviors—a considerable challenge in material design. In our previous systematic investigation of 16 binary Zn-RE alloys, we found that six RE elements (Y, Gd, Eu, Nd, Sm) could significantly enhance the strength of pure Zn and improve corrosion uniformity by refining equiaxed grains and promoting secondary phase precipitation17. Since equiaxed grains still constitute a major fraction of the ZLM alloy microstructure, we hypothesized that introducing Y, Gd, Eu, Nd, and Sm could further refine these grains, thereby improving mechanical strength, corrosion uniformity, and osteogenic activity. In the present study, we developed a series of ZLM-RE alloys (RE = 0.3/0.5 Y, 0.3 Gd, 0.3 Eu, 0.3 Nd, 0.3 Sm). The RE elements predominantly exist as REZn₁₁-₁₃ intermetallic compounds within the ZLM alloy matrix, mainly distributed in equiaxed regions, while no RE-containing phases were detected within the eutectoid microstructure. Notably, Li-RE alloying reactions are rarely reported in Zn alloys. In Mg alloys, Sm and Gd primarily form Mg₄₁Sm₅ and Mg₂Gd phases, respectively, without reacting with Li18,19. Among the alloys investigated, ZLM-0.5Y exhibits the highest ultimate tensile strength of 772 MPa—approximately a 40% increase relative to the base ZLM alloy—and approaches the strength level of Ti-6Al-4V (Fig. 1E). EBSD and TEM analyses revealed three distinct microstructural features in ZLM-0.5Y alloy compared with ZLM alloy (Fig. 7A): (1) a bimodal grain size distribution, with fine grains (<10 μm) and approximately 25% coarse grains (~50 μm) (Fig. 2A); (2) a nearly seven-fold increase in texture intensity (Fig. 2A); and (3) YZn₁₂ phases mainly distributed within equiaxed regions and forming incoherent interfaces with the Zn matrix (Fig. 2B), accompanied by pronounced local stress concentrations (Fig. 2A). The observed bimodal grain distribution likely originates from the presence of YZn₁₂ and its partial suppression of dynamic recrystallization in Zn grains. Bimodal structures inherently produce heterogeneous deformation between soft fine-grained and hard coarse-grained zones, generating strain gradients, geometrically necessary dislocations (GNDs), and back-stresses that collectively enhance overall strength20,21. The incoherent interface between YZn₁₂ and Zn results in atomic misalignment on the Zn side, where stress concentration and dislocation pile-up occur, further contributing to strengthening. In hexagonal close-packed (HCP) metals, extrusion commonly induces basal fiber textures due to the high activity of basal slip systems22. Because Zn has a c/a ratio of 1.856 > 1.633, the critical resolved shear stress (CRSS) for pyramidal slip is lower than that for prismatic slip; thus, the combined activity of basal and pyramidal systems produces a texture with basal poles tilted toward the extrusion direction (ED) (Fig. 2A). In Zn-Li alloys, a dual texture associated with the eutectoid microstructure is also observed, and the maximum texture intensity increases 8 times relative to pure Zn. In ZLM-0.5Y, similar texture with same intensity is observed. Such textural strengthening alters the Schmid factor distribution relative to the loading direction, thereby modifying the CRSS contributions of individual slip systems and reducing their activation likelihood. Additionally, the significant misorientation between YZn₁₂ and Zn equiaxed grains induces local stress fields that hinder dislocation motion, synergistically amplifying the strengthening effect of both texture and precipitation. During the in situ tensile experiments, the YZn₁₂ phase develops localized stress concentration with increasing strain, and microcracks initiate at the yield point. These cracks subsequently propagate into the surrounding equiaxed Zn grains, ultimately leading to macroscopic fracture of the material (Fig. 3A). This process clearly demonstrates the strengthening role of the hard and brittle YZn₁₂ phase when it is embedded in the Zn matrix with a large crystallographic misorientation, forming non-coherent interfaces with the Zn phase. However, the development of strong textures inevitably compromises ductility. From a biological perspective, an ideal bone implant material must possess not only excellent mechanical properties but also superior osteogenic capability. In a rat femoral condyle critical-sized defect model, implants of ZLM-0.5Y and ZLM-0.5Gd exhibited substantially greater new bone formation one-month post-implantation compared with Ti-6Al-4V controls (Fig. 5). This enhanced osteogenesis likely arises from ion release during alloy degradation. XRF elemental mapping revealed relatively low Zn concentrations in the surrounding tissue, while RE elements remained confined within the implant in the form of intermetallic compounds, with no detectable RE signal in the adjacent tissue (Fig. 6A). Notably, the apparent Y signal were observed in tissue in the ZLM-Y group. This is because the continuous spectrum of the Rh target X-rays has a very strong intensity in the 10–20 keV range. After undergoing Compton scattering, this portion of the radiation produces a broad and intense scattered background concentrated in the 5–15 keV region. The atomic number of Y is 39, and its Kα energy is 14.96 keV, which happens to fall right within this region of strong scattered background. As a result, its signal peaks appear to sit atop a high “noise hill.” Therefore, the enhanced osteogenic performance of ZLM-RE alloys is primarily ascribed to the modified Zn release behavior. XRD analysis confirmed that ZLM-RE alloys (RE = Y, Eu, Gd, Nd, Sm) consist of Zn, LiZn₄, and REZn₁₁-₁₃ phases (Fig. 4D). The electrode potentials of Y (–2.37 V), Eu (–2.81 V), Gd (–2.28 V), Nd (–2.10 V), and Sm (–2.68 V) fall between those of Zn (–0.76 V) and Li (–3.04 V). Consequently, a three-electrode system is established among REZn₁₁-₁₃, Zn, and LiZn₄ phases, wherein the REZn₁₁-₁₃ phase acts as a potential buffer according to the mixed potential theory (Fig. 8B). Taking ZLM-0.5Y as an example, the originally large potential difference between Zn and LiZn₄ (EZn-ELiZn₄) is divided into two smaller differences (EZn-EYZn₁₃ and EYZn₁₃- ELiZn₄), thereby reducing galvanic corrosion driving force, corrosion current, and improving corrosion uniformity. As shown in Fig. 4 and Supplementary Table 2, ZLM-RE alloys exhibit markedly lower corrosion current densities than ZLM, while EIS results reveal enlarged impedance arc radii, indicating enhanced corrosion resistance. Both in vitro and in vivo tests (Figs. 4B and 6B) confirm that ZLM-RE alloys degrade predominantly through a macroscopically uniform corrosion mode. Accordingly, the REZn₁₁-₁₃ phase effectively regulates the alloy’s degradation kinetics and uniformity, thereby modulating Zn ion release and promoting new bone formation. Transcriptomic analysis further suggests that Zn-based degradation products may activate the Rap1 signaling pathway, thereby enhancing osteogenesis (Fig. 8C). Rap1 GTPase signaling pathway plays a critical regulatory role in bone regeneration. First, in terms of differentiation regulation, Rap1 can be activated by extracellular signals, which then significantly promote the differentiation of mesenchymal stem cells into osteoblasts through downstream pathways like MEK/ERK and PI3K/Akt23,24. Second, at the cellular behavior level, Rap1 is a key regulator of integrin activity. It activates integrins via the “inside-out” signaling mechanism, greatly enhancing osteoblast adhesion to extracellular matrix components (such as Type I collagen and fibronectin), which is crucial for cell spreading, migration, and proper positioning at the bone repair site25. Finally, at the functional execution level, the activated Rap1 pathway upregulates the expression of osteogenic marker genes, including alkaline phosphatase (ALP) and osteocalcin (Osteocalcin), directly driving bone matrix synthesis and mineralization26. To further improve the strength limit of biodegradable zinc alloys, this study introduced trace amounts of RE elements Y, Eu, Gd, Nd, and Sm into a previously developed Zn-0.8Li-0.1Mn alloy to form REZn₁₁-₁₃ strengthening phases. These phases inhibit the dynamic recrystallization of equiaxed Zn grains, resulting in a bimodal grain structure that, together with the eutectic ultrafine lamellar structure, significantly enhances the strength of the Zn-Li-Mn alloy. Among them, the ZLM-0.5Y alloy achieved a UTS of 772 MPa, approaching the strength level of the Ti-6Al-4V alloy. Meanwhile, the REZn₁₁-₁₃ phase exhibits an intermediate electrochemical potential, serving as a “potential buffer” that reduces the galvanic corrosion current density within the ZLM alloys and improves both degradation uniformity and Zn-dominated ion release behavior. Compared with the Ti-6Al-4V alloy, the ZLM-0.5Y and ZLM-0.3Gd alloys doubled new bone formation during critical-sized bone defect repair. Overall, the designed ZLM-0.5Y alloy simultaneously achieves optimal mechanical strength and osteogenic activity, establishing a material foundation for the application of biodegradable metals in the repair of load-bearing bone injuries. Methods Sample preparation The alloy materials used in this study were provided by the Hunan Rare Earth Metal Materials Research Institute. The as-cast alloys were subjected to a heat treatment at 260 °C for 2 h, followed by extrusion with an extrusion ratio of 16:1 to obtain rods with a diameter of 10 mm. The extruded rods were then sliced into circular samples with a diameter of 10 mm and a height of 1 mm using wire cutting, and sequentially polished with 400#, 800#, 2000#, 5000#, and 7000# sandpaper to obtain smooth and flat surfaces. Bone implant sample preparation Cylindrical samples with a diameter of 1.5 mm and a height of 5 mm were cut along the extrusion direction. The surfaces were polished using 400#, 800#, and 2000# sandpaper to achieve a smooth and flat finish. The samples were then ultrasonically cleaned in acetone and anhydrous ethanol, dried, and sterilized by ethylene oxide for animal implantation. Mechanical testing Tensile, compression, and bending samples were prepared according to ASTM-E8-04a, ASTM E9-89a, and ASTM E290-97 standards, cut along the extrusion direction. After surface grinding and polishing, the samples were subjected to tests using an Instron 5969 universal testing machine. The gauge length was set to 25, 15, and 25 mm for tension, compression, and bending, respectively, and the strain rate was 1 × 10−4/s. The tests were performed at room temperature. 3–5 parallel samples were tested for each group, and the yield strength was taken as the stress corresponding to 0.2% plastic deformation. For in situ tension test, the sample gauge was set to 2 mm, and the strain rate was 1.5 μm/s. Thermo Scientific™ Apreo was adopted with Thermo Scientific SmartAlign technique for in situ test. The creep experiment was conducted in accordance with the GB/T 2039 2024 using a GNCJ100E creep testing machine (NCS, China). Specimens were cylindrical rods with dimensions of φ10 mm × 91 mm. The stress was set to 30% of the material’s yield strength (110 MPa for ZLM and 208 MPa for ZLM-0.5Y), with a loading duration of 15 hours. Temperature was maintained at 37 °C by an Eurotherm controller coupled with a platinum rhodium (type S) thermocouple, and regulated via a programmed tablet (Pad). Metallographic observation The metal discs obtained by wire cutting were polished to 2000# using sandpaper, followed by polishing treatment. The samples were etched with a 4% nitric acid alcohol solution for 15–30 s, then rinsed with alcohol and deionized water and blow-dried. The microstructure of the alloys was observed under a metallographic microscope. X-ray diffraction (XRD) analysis Phase analysis of the circular samples was performed using a Rigaku DMAX 2400 X-ray diffractometer. The test conditions were: Cu Kα radiation, voltage of 40 kV, current of 100 mA, scanning range from 10° to 90°, step size of 0.02°, and scanning speed of 4°/min. Electron backscatter diffraction (EBSD) analysis To minimize oxidation of the sample in air, after ion beam polishing, the sample was immediately mounted onto the sample holder using conductive silver paste and allowed it to cure before transferring it into the SEM chamber for EBSD analysis. The EBSD specimen was initially subjected to a series of mechanical grinding steps using silicon carbide papers (from 400# to 5000# grit) followed by mechanical polishing to obtain a flat and scratch-free surface. Subsequently, a final treatment was performed using an IM4000II argon ion polishing system to eliminate the surface deformation layer. This ion milling was conducted at voltages of 4 keV and 3 keV, each for a duration of 0.5 h. EBSD measurements were carried out in a scanning electron microscope equipped with an EDAX Velocity Super EBSD detector. The experiment was conducted under conditions of a 20 kV accelerating voltage and a 6.4 nA beam current, with the sample tilted at 70° relative to the horizontal. The scan step size was appropriately chosen based on the actual grain size of the zinc alloy to ensure effective resolution of the microstructural details. The acquired EBSD data were processed using spherical indexing with EDAX OIM Analysis™ software for analysis of crystal orientation maps, grain boundary distribution, and texture. Transmission electron microscopy (TEM) analysis The zinc alloy sample was progressively ground to a thickness of approximately 100 μm using water-cooled silicon carbide papers, with a final step employing 5000# grit paper. A 3 mm diameter disc was then punched out and further finely ground to about 50 μm. Final thinning was performed using an ion polisher. The initial stage utilized a 5 keV ion beam energy at incident angles of ±8° until perforation occurred. This was followed by a final stage at 3.5 keV and ±3° for approximately 30 minutes to obtain an electron-transparent thin area suitable for observation. TEM observation was conducted on an FEI Tecnai G2 F20 field-emission transmission electron microscope operating at an accelerating voltage of 200 kV. Bright-field imaging, high-resolution imaging, and selected area electron diffraction (SAED) techniques were employed to investigate the microstructure and crystallographic characteristics of the sample. Microhardness testing Microhardness was measured using a Shimadzu HMV-2T microhardness tester. The load was set to 980.7 mN, and the dwell time was 15 s. Three samples of each material were tested, and five measurements were taken from each sample. The average value was calculated and statistically analyzed. Immersion experiment Following ASTM-G31-72 standards, zinc alloy discs polished to 2000# were immersed in simulated body fluid (SBF) for the immersion experiment. The solution-to-sample surface area ratio was maintained at 20 mL/cm², and the temperature was kept at 37 °C. Five parallel samples were used for each group. The immersion period lasted for 28 days, during which the pH change was monitored. After the experiment, the samples were cleaned, dried, and characterized for corrosion morphology, product composition, and structure using imaging measurements, SEM/EDS, XRD, FTIR, and XPS. According to ASTM-G1-90, corrosion products were removed using a 200 g/L CrO₃ solution under ultrasonic treatment. The mass loss and corrosion rate were calculated, and the ion concentration in the immersion solution was analyzed by ICP-OES. Electrochemical test Electrochemical measurements were performed using a three-electrode system, in which the investigated material served as the working electrode, a saturated calomel electrode (SCE) as the reference electrode, and a platinum sheet as the counter electrode. All tests were conducted in simulated body fluid (SBF) solution maintained at 37 °C. The open circuit potential (OCP) of the sample in SBF was first recorded for 3600 s to ensure system stabilization. Subsequently, electrochemical impedance spectroscopy (EIS) was carried out at the OCP over a frequency range from 105 Hz to 10−2 Hz. Potentiodynamic polarization (PDP) tests were then performed by scanning the potential from –500 mV to +500 mV relative to the OCP at a scan rate of 1 mV/s. Following the ASTM G102 89 standard, key corrosion parameters including corrosion potential (Ecorr) and corrosion current density (icorr) were extracted by Tafel extrapolation. Cell culture MC3T3-E1 cells were purchased from Shanghai Fuheng Biotechnology Co., Ltd. (Cat No. FH0384). Cells were cultured at 37 °C in 5% CO₂ conditions, with media replaced every 2–3 days. When the cell confluence reached 70–80%, cells were passaged using 0.25% trypsin containing EDTA. The cell morphology and growth state were regularly monitored. The ion concentration in the immersion solution was analyzed by inductively coupled plasma optical emission spectrometry (ICP-OES, iCAP 6300, Thermo). Preparation of extracts Zinc alloy samples with a diameter of 10 mm and a height of 1 mm were polished and cleaned with acetone and anhydrous ethanol, followed by sterilization under UV light for 4 h on each side. According to ISO10993-12 standards, the samples were immersed in cell culture medium at a ratio of 1.25 cm²/mL and incubated at 37 °C in 5% CO₂ for 24 h. The medium was then filtered, stored at 4 °C, and reserved for use. Cytotoxicity assay Cells were seeded at a density of 5 × 104 cells/well in a 96-well plate. After 24 h, the medium was replaced with extracts (diluted 0–3 times) and cultured for 1, 2, and 4 days. Cell viability was assessed using the CCK-8 kit, and the absorbance at 450 nm was measured using a microplate reader. Live/dead staining was performed using Calcein AM and PI dyes, and cell viability was observed under a fluorescence microscope. Cell adhesion Cells were seeded in wells coated with cover slips and cultured for 4 h to allow attachment. After replacing the medium with the extract, cells were cultured for the desired period. After fixing with 4% paraformaldehyde, cells were stained with FITC and DAPI, and observed under a confocal microscope to analyze the cytoskeleton and nuclear morphology. ALP staining and quantification At days 7 and 14, cells were fixed and stained with BCIP/NBT for ALP activity. After RIPA lysis, protein concentration was determined by the BCA method, and ALP activity was measured using an alkaline phosphatase assay kit at a wavelength of 405 nm. Results were expressed as U/mg protein. Calcium deposition staining On day 14, samples were fixed with 4% paraformaldehyde and stained with ARS staining solution for 30 min under light protection. After washing with distilled water, calcium nodule formation was recorded by scanning. Immunofluorescence and qPCR analysis BMP2 expression was analyzed by immunofluorescence using rabbit anti-mouse BMP2 as the primary antibody and FITC-labeled goat anti-rabbit IgG as the secondary antibody. For qPCR analysis, total RNA was extracted from cells, reverse-transcribed to cDNA, and gene expression levels of Runx2, ALP, Osx, OPN, and COL1 were detected using the SYBR Green method. Animal experiments All animal experiments were conducted in compliance with the animal life protection standards and procedures approved by Shanghai Yishang Biotechnology Co., Ltd. (IACUC 2024-Mi-026). For the implantation study, 8-week-old male Sprague-Dawley rats weighing 220 g were procured from Shanghai Yishang Biotechnology Co., Ltd. (SCXK (HU) 2022-0011). Surgical procedures were performed under aseptic conditions. Preoperative instruments were sterilized using high-temperature high-pressure methods, and the surgery was conducted under sterile conditions. After weighing the experimental rats, anesthesia was induced by intramuscular (IM) injection of ketamine (75 mg/kg) and 2% xylazine (5 mg/kg). Body temperature was maintained throughout the anesthesia period. Once the animals were fully anesthetized (complete loss of consciousness), the right hind limb was fixed, disinfected with iodophor, and draped. A lateral parapatellar approach was used to sequentially incise the tissue and perform subperiosteal dissection, exposing the femoral condyle. A cylindrical bone defect (Φ1.5 mm × 5 mm) was created on the articular surface of the lateral femoral condyle using a 1.5 mm diameter drill. The defect was irrigated with sterile saline until no bone fragments or bone marrow residues remained. The defect was then filled with various Zinc alloy rods (ZLM-0.5Y/0.3Y/Eu/Gd/Nd/Sm and Ti-6-Al4-V), after which the incision was sutured. The animals were kept warm and monitored during recovery. Postoperatively, carprofen (5 mg/kg) was administered subcutaneously for analgesia. The rats were euthanized at 1 month, and 3 months post-implantation. Collect blood samples for complete blood count (CBC) analysis. The entire implanted femur was collected and fixed in 4% paraformaldehyde solution for 72 h. Micro-CT analysis Femurs were first scanned using a Micro-CT system (Skyscan1176, USA Bruker). Implanted rat femurs were examined with the 18 µm resolution protocol (40 kV, 250 uA). The CT scanning images were reconstructed by using NRecon software (Bruker microCT, Kontich, Belgium) and further analyzed by CTAn, CTVol, and CTVox software to produce 3D images and bone morphometry analysis including new bone formation (BV/TV) and so on.After Micro-CT scanning, specimens were fixed in 4% paraformaldehyde for 48 h, followed by 24 h of running water rinsing. Histological evaluation After Micro-CT scanning, specimens were fixed in 4% paraformaldehyde for 48 h, followed by 24 h of running water rinsing. Hard Tissue Sectioning: Fixed samples were first dehydrated using an ascending ethanol gradient (70–100%), with 24 h at each concentration. Samples were then sequentially immersed in two solutions—anhydrous ethanol + Technovit 7200 resin infiltration solution (ratio 3:7), followed by anhydrous ethanol + Technovit 7200 resin infiltration solution (ratio 1:1)—each for 2 days. This was followed by immersion in Technovit 7200 resin solution for 7 days, after which the solution was replaced and immersion continued for another 3 days. The dehydrated samples were embedded and polymerized under a light-curing unit. The tissue blocks were sectioned without decalcification using a hard tissue microtome at a thickness of 200 μm. Sections were ground to a final thickness of 100 μm using a grinding machine and subsequently polished (this step was performed by Shanghai Ruibaohe Biotechnology Co., Ltd.). Samples were grounded and polished before drying in air. Then, sample surface was coated with a layer of gold and recorded using a SEM. Conventional Paraffin Sectioning: For bone tissue samples, decalcification was performed using 10% EDTA decalcification solution, which was replaced daily until the bone tissue softened and the rod could be carefully removed without resistance from a fine needle. After 24 h of running water rinsing to remove acid, samples were dehydrated in an ascending ethanol gradient (70–100%), with 1 h at each concentration. Following dehydration, samples were cleared in xylene and embedded in PMMA-infiltrated paraffin. Sections were cut using a paraffin microtome to a thickness of ≤5 μm. Sections were sequentially placed in xylene I and II for 10 min each, followed by an ethanol gradient (100%, 90%, 80%, 70%) for 5 min each for dewaxing. Sections were rinsed in pure water for 5 min and washed with TBS for 3 min, repeated 3 times. H&E Staining: Processed sections were stained with hematoxylin for 5 min, rinsed with tap water to remove excess stain, and washed with pure water for several seconds. Differentiation was performed using hydrochloric acid–ethanol differentiation solution for several seconds, followed by tap water rinsing for bluing. Sections were then stained with eosin for several seconds, dehydrated through an ascending ethanol gradient (70–100%) for 10 s each, and cleared in xylene three times for 5 min each. Finally, sections were mounted with neutral balsam and observed under an optical microscope, with images captured using a high-throughput digital slide scanning system. Masson Staining: Sections were stained with hematoxylin for 5 min and rinsed with pure water for 5 min. Appropriate acidic differentiation solution was applied for 30 s, followed by tap water rinsing for 10 min for bluing, and one wash with pure water. Staining was performed with Ponceau–acid fuchsin staining solution for 10 min, followed by a quick pure water wash. Differentiation was carried out with phosphomolybdic acid solution for 2 min, followed by a quick pure water wash. Sections were stained with bright green staining solution for 1 min and quickly washed with pure water. A final differentiation step was performed using acidic differentiation solution for 1 min, followed by a quick pure water wash. Subsequent dehydration, clearing, mounting, observation, and imaging steps were consistent with those described above. Toluidine Blue–Acid Fuchsin Staining: Sections were stained with toluidine blue staining solution for 10–20 min and washed once with pure water. After air-drying at room temperature, sections were stained with acid fuchsin staining solution for 5 min and washed once with pure water. Subsequent steps were consistent with those described above. X-ray fluorescence The hard tissue sectionings were examined using an X-ray fluorescence (XRF, Bruker M4 Tornado, Germany). The X-ray generator functioned at 50 kV with a current of 600 μA. To minimize background interference, a filter composition of 100 µm of aluminum, 50 µm of titanium, and 25 µm of copper was employed. Elemental mappings were executed in a vacuum environment of 20 mbar directly on the sectioned samples. The lateral step size was set at 20 µm, and each pixel was exposed for 5 ms. For XRF data acquisition and processing, the instrument’s proprietary Bruker software was utilized. Quantification of the results was conducted through the fundamental parameter method designed for bulk samples. Immunohistochemical staining Pretreatment After dewaxing and rehydration, paraffin sections of tissues and organs were subjected to antigen retrieval using antigen retrieval buffer. After cooling naturally to room temperature, sections were washed with PBS. A solution of hydrogen dioxide in pure water (1:9 ratio) was prepared, and sections were incubated in this solution for 25 min at room temperature in the dark to block endogenous peroxidase activity. A 3% BSA solution was applied to fully cover the tissue within the marking circle, and sections were blocked at room temperature for 30 min. The following antibodies were used in this study Anti-BMP2 antibody (Abcam, Cat#ab214821, Lot#EPR20807) for immunofluorescence (IF) at a dilution of 1:500, Anti-Collagen I antibody (Abcam, Cat#ab270993, Lot#EPR24331-53) for immunohistochemistry (IHC) at 1:200, Rabbit polyclonal Osteopontin antibody (Abcam, Cat#ab216402) for IHC at 1:250, IL-10 rabbit polyclonal antibody (ABclonal, Cat#A2171) for IHC at 1:100, and Anti-TNF-α antibody (Abcam, Cat#ab215188, Lot#EPR20972) for IHC at 1:500. Antibody labeling Primary antibodies, diluted to the appropriate ratio for each antibody, were applied to the blocked sections and incubated overnight at 4 °C in a humidified chamber. After thorough washing with PBS, corresponding secondary antibodies were applied and incubated for 50 min at room temperature. Detection After washing, DAB chromogenic solution was applied within the marking circle. Color development was monitored under a microscope, and the reaction was stopped by rinsing with tap water. Sections were then counterstained for nuclei, dehydrated, mounted with resin, and observed under a microscope. RNA-Seq Total RNA was extracted from MC3T3 cells, and after quality assessment, chain-specific cDNA libraries were constructed. Sequencing was performed on the Illumina platform. The data were aligned to the reference genome, followed by differential gene expression analysis. Statistical analysis The numerical data were evaluated using GraphPad Prism 10 software (GraphPad Software, La Jolla CA, USA) and Origin 2024b (Originlab, Northampton MA, USA) by one-way analysis of variance (ANOVA) followed by post hoc Tukey’s multiple comparison test. The data were presented as mean ± SD (n ≥ 3, independent samples) and a difference of *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 were considered as statistically significant. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary Information Reporting Summary Transparent Peer Review file Source data Source data Acknowledgements Y.Zhu and Y.Wu at Boyue Instruments (Shanghai) Co., Ltd. offered great help in analyzing the results of XRF data. Author contributions Jiahui Shi: Led the formal analysis, investigation, and original draft preparation; contributed equally to the methodology. Mingyu Qu: Contributed equally to the investigation, methodology, and original draft preparation. Chaoyang Sun: Contributed equally to the investigation and methodology. Shuang Li: Provided supporting roles in investigation and methodology. Jialian Xu: Provided supporting methodology. Ting Zhang: Provided supporting resources. Xinhua Qu: Contributed equally to conceptualization, funding acquisition, project administration, supervision, and writing (review and editing). Hongtao Yang: Led the writing (review and editing); contributed equally to conceptualization, methodology, supervision, and original draft preparation. Yufeng Zheng: Led the conceptualization, funding acquisition, project administration, and supervision; contributed equally to writing (review and editing). Peer review Peer review information Nature Communications thanks Ehsan Farabi and the other anonymous reviewer for their contribution to the peer review of this work. A peer review file is available. Funding This work is supported by the National Natural Science Foundation of China (Grant Nos. U22 A20121, 32471399, 32222042, 82172453), the NSFC-RGC Joint Research Scheme (52361165619), the NSFC-RFBR Joint Research Scheme (82361138575), the 9th Young Elite Scientist Sponsorship Program by CAST (No. YESS20230124), the National Key Research and Development Program of China (2023YFC2509600), the Fundamental Research Funds for the Central Universities (Grant No. YWF-23-YG-QB-039), and the Guangdong Basic and Applied Basic Research Foundation (Grant No. 2024A1515012042). Data availability The authors declare that all data supporting the findings of this study are available within this paper and its Supplementary Files. Source data is available for Figs. 1B, D, 2A, 3B, C, 4A, C, D, and 5A, B in the associated source data file. The RNAseq data generated in this study have been deposited in the NIH National Center for Biotechnology Information Bioproject database under accession number PRJNA1417620. Source data are provided with this paper. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Jiahui Shi, Mingyu Qu, Chaoyang Sun. Contributor Information Xinhua Qu, Email: quxinhua@renji.com. Hongtao Yang, Email: yang276070@buaa.edu.cn. Yufeng Zheng, Email: yfzheng@pku.edu.cn. Supplementary information The online version contains supplementary material available at 10.1038/s41467-026-74069-x. References Associated Data Supplementary Materials Supplementary Information Reporting Summary Transparent Peer Review file Source data Data Availability Statement The authors declare that all data supporting the findings of this study are available within this paper and its Supplementary Files. Source data is available for Figs. 1B, D, 2A, 3B, C, 4A, C, D, and 5A, B in the associated source data file. The RNAseq data generated in this study have been deposited in the NIH National Center for Biotechnology Information Bioproject database under accession number PRJNA1417620. Source data are provided with this paper.